ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,714.05
      0.20%
      US Tech 100
      19,326.40
      0.15%
      Dow Jones
      42,087.75
      0.06%
      Brent Oil
      72.575
      -1.77%
      Bitcoin
      63,306.78
      -0.50%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Aegerion Pharmaceuticals, Inc. (AEGR) Quote

      Aegerion Pharmaceuticals, Inc.

      Aegerion Pharmaceuticals, Inc. (AEGR)

      NASDAQ
      1.97
      0.00
      ( 0.00% )
      Updated: 20:00:00
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      1.97
      Bid
      1.91
      Ask
      1.97
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      1.97
      Open
      -
      Last Trade
      Last Trade Time
      -
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      AEGR Latest News

      More News

      Aegerion Pharmaceuticals, Inc. and QLT Inc. Complete Merger Transaction; QLT to Change Name to Novelion Therapeutics Inc.

      -- Transaction creates strong, diversified rare-disease focused portfolio-- Novelion Therapeutics completes concurrent financing of approximately $22 million -- Company to host conference call...

      November 29 2016
      GlobeNewswire Inc.

      Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules for the Treatment of Homozygous Familial Hypercholesterolemia (H...

      CAMBRIDGE, Mass., Nov. 17, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...

      November 17 2016
      GlobeNewswire Inc.

      Aegerion Pharmaceuticals Announces Third Quarter 2016 Financial Results

      CAMBRIDGE, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...

      November 03 2016
      GlobeNewswire Inc.

      Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules Approved in Japan for the Treatment of Homozygous Familial Hyper...

      CAMBRIDGE, Mass., Sept. 28, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...

      September 28 2016
      GlobeNewswire Inc.

      Aegerion Pharmaceuticals Observes Familial Hypercholesterolemia Awareness Day

      CAMBRIDGE, Mass., Sept. 24, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company focused on the development and commercialization of novel...

      September 24 2016
      GlobeNewswire Inc.

      Aegerion Pharmaceuticals Appoints Remi Menes as Chief Commercial Officer

      CAMBRIDGE, Mass., Sept. 20, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...

      September 20 2016
      GlobeNewswire Inc.

      Aegerion Pharmaceuticals Announces Second Quarter 2016 Financial Results

      -- Company records $44.5 million in total net product sales Company reiterates 2016 total net product sales guidance of between $130 and $150 million -- CAMBRIDGE, Mass., Aug. 09, 2016...

      August 09 2016
      GlobeNewswire Inc.

      Cohera Medical, Inc.® Appoints Paul Thomas to its Board of Directors

      RALEIGH, N.C., July 25, 2016 (GLOBE NEWSWIRE) -- Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, announced today the appointment of Paul...

      July 25 2016
      GlobeNewswire Inc.

      Aegerion Pharmaceuticals Announces Cost Reduction Plans

      CAMBRIDGE, Mass., July 20, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...

      July 20 2016
      GlobeNewswire Inc.

      Update in Lawsuit for Investors in Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) shares announced by Shareholders Foundation

      SAN DIEGO, June 21, 2016 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending in Massachusetts on behalf of certain purchasers of shares of Aegerion...

      June 21 2016
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      KAVLKaival Brands Innovations Group Inc
      $ 1.475
      (154.75%)
      		130.93M
      TGLTreasure Global Inc
      $ 1.1008
      (61.81%)
      		125.42M
      NVVENuvve Holding Corporation
      $ 6.30
      (60.71%)
      		27.07M
      NUKKNukkleus Inc
      $ 0.3343
      (57.32%)
      		52.02M
      UXINUxin Ltd
      $ 2.36
      (48.90%)
      		8.5M
      ELABElevai Labs Inc
      $ 0.1105
      (-60.54%)
      		12.51M
      ADTXAditxt Inc
      $ 0.2676
      (-30.06%)
      		1.94M
      FRGTFreight Technologies Inc
      $ 0.0814
      (-28.47%)
      		20.83M
      ZJYLJin Medical International Ltd
      $ 2.92
      (-28.43%)
      		671.33k
      PRFXPainReform Ltd
      $ 0.60
      (-22.19%)
      		296.55k
      XPONExpion360 Inc
      $ 0.10325
      (21.76%)
      		356.8M
      KAVLKaival Brands Innovations Group Inc
      $ 1.475
      (154.75%)
      		130.93M
      TGLTreasure Global Inc
      $ 1.1008
      (61.81%)
      		125.42M
      NVDANVIDIA Corporation
      $ 116.12
      (0.10%)
      		103.65M
      INTCIntel Corporation
      $ 22.4725
      (2.90%)
      		102.33M

      Discussion

      View Full Feed
      Golden Cross Golden Cross 1 minute ago
      $XXII FDA modified tobacco risk designation...95 percent less nicotine.

      [yt]5cc7nZMLiZI[/yt]
      XXII
      SCAMBUSTERKING SCAMBUSTERKING 1 minute ago
      Keep buying!!! This is your big moment!
      BCAP
      northam43 northam43 2 minutes ago
      Report #1 Status Report. The 60 min level is at -18, the 60-1 & 60-E-1 are extremely overdue

      https://investorshub.advfn.com/uimage/uploads/2024/9/23/chcud1_Status_Report.PNG
      MasterBlastr MasterBlastr 2 minutes ago
      Thanks - on balance.
      peterus peterus 2 minutes ago
      you just born stupid ? 0.08s today
      MAXN
      Samuel J Samuel J 2 minutes ago
      He’s not a low life trying to buy cheap shares like someone I know too damn well.
      TGRP
      blackhawks blackhawks 2 minutes ago
      This Modern World by Tom Tomorrow

      https://cdn.prod.dailykos.com/images/1348465/story_image/TMW2024-09-23color.png
      Golden Cross Golden Cross 2 minutes ago
      $XXII FDA modified tobacco risk designation...95 percent less nicotine.

      [yt]5cc7nZMLiZI[/yt]
      XXII
      TJG TJG 2 minutes ago
      Five min ago I posted we needed the information and also speculated the Q&A would be this evening after the work day was completed... Thanks for posting this information EyeIn TheSky... looking forward to being there...
      PHBI
      Susie924 Susie924 2 minutes ago
      Zingbot made Angela know how much she is disliked
      Zorax Zorax 2 minutes ago
      Something to think about you can say all you want but we took in around 20 Million people we have no idea who the are and you take our nuts then you take a percentage of the 20 Mill with a screw lose that gets real ugly.You are propagating a lie. First please supply a link to that 20 million and in
      toastturtle toastturtle 3 minutes ago
      It is public information, you can look it up on Sedi but I will save you time. https://ceo.ca/api/sedi?symbol=rht&amount=&transaction=&insider=
      RQHTF
      Samuel J Samuel J 3 minutes ago
      Dino has helped me so much people like you wouldn’t understand. It also goes way more than just money.

      Can anyone say anything close to what u just said about you CLOWN 🤡
      TGRP
      Wayne R Wayne R 3 minutes ago
      Alien communication, intermittent signals.

      It all makes sense.
      PennyMillions852 PennyMillions852 3 minutes ago
      Enough filled! LFG!!!!!!!!!!!!!!!!!!
      IGPK
      QuicKtip QuicKtip 3 minutes ago
      $CBDW 1606 Corporation Forges Ahead with Strategic Stake in Adnexus https://allcapresearch.com/f/1606-corporation-forges-ahead-with-strategic-stake-in-adnexus
      CBDW
      QuicKtip QuicKtip 3 minutes ago
      $CBDW 1606 Corporation Forges Ahead with Strategic Stake in Adnexus https://allcapresearch.com/f/1606-corporation-forges-ahead-with-strategic-stake-in-adnexus
      CBDW
      KngmAz KngmAz 3 minutes ago
      Probably before that.
      MULN
      ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 3 minutes ago
      TGRP~~clown artist Dino wants bad out, ask him, he bout .30+++
      TGRP
      TrendTrade2016 TrendTrade2016 4 minutes ago
      SLIGHTLY DIFFERENT DEPENDS ON THE CLOW SHOW...SOME GET MORE DETAILS....SOME GET LESS...BUT THIS SCAM NEEDS SPECIAL ATTENTION
      CLOW
      dinogreeves dinogreeves 4 minutes ago
      Ukrainian Army will be here soon.
      TGRP
      Milesblue42 Milesblue42 4 minutes ago
      cojoboy, focus on Ceo Ronn Ford

      Amazing..one agrees with the bashers in sarcasm.. And they disappear.. Can one say "bot".??

      Making Idiotic excuses for the person, Ronn Ford, diluting sounds incredibly silly.
      RONN
      Milesblue42 Milesblue42 4 minutes ago
      cojoboy, focus on Ceo Ronn Ford

      Amazing..one agrees with the bashers in sarcasm.. And they disappear.. Can one say "bot".??

      Making Idiotic excuses for the person, Ronn Ford, diluting sounds incredibly silly.
      RONN
      EnchantedTitan62 EnchantedTitan62 4 minutes ago
      I could be wrong, but it probably takes a few weeks to compile all the data. I'm quite optimistic . 🍷
      TGRP

      Your Recent History

      NASDAQ
      AEGR
      Delayed Upgrade Clock